Trial intelligence / Profile preview

Escitalopram Neuroimaging in Depression

NCT00343070Phase 2Completed

Sponsor
Ghent University Hospital
Start
Mar 2007
Primary completion
Oct 2009
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Escitalopram oxalate oral solution in major depressive disorder (MDD), sponsored by Ghent University Hospital. Started Mar 2007; status: completed.

02

Drugs

Escitalopram oxalate oral solution
03

Conditions

major depressive disorder (MDD)

Beyond the preview

Go deeper on NCT00343070.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00343070.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call